Why is Amazon expanding same-day grocery delivery?
How will Air Canada flight cancellations affect travel?
What are the impacts of Trump's chip deal with Nvidia?
Why is the BLS jobs data report under scrutiny?
How is Walmart's new grocery discount aiding employees?
What led to the surge in crypto exchange Bullish’s IPO?
Why is GE Appliances shifting production to the US?
Amphastar Secures FDA Nod For Iron Sucrose Injection, Analysts Eye Major Sales Momentum
benzinga.com/analyst-stock-ratings/analyst-color/25/08/47069082/amphastar-secures-fda-nod-for-iron-sucrose-injection-analysts-eye-major-sales
On Monday, the U.S. Food and Drug Administration (FDA) approved Amphastar Pharmaceuticals, Inc.’s (NASDAQ:AMPH) Abbreviated New Drug Application (ANDA) for Iron Sucrose Injection, USP 50mg/2.5mL, 100mg/5mL, and 200mg/10mL in single-dose vials, previously referred to as AMP-002.
Iron…
This story appeared on benzinga.com, 2025-08-12 17:38:58.